Elevance Health Inc. (ELV) Tops Q3 EPS by 108c

Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $6.03, $1.08 better than the analyst estimate of $4.95. Revenue for the quarter came in at $50.09 billion versus the consensus estimate of $49.34 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Wealthfront launches custodial account with tax-gain harvesting
• UK’s EG Group reportedly files for US IPO worth about $1 billion